Chethan Puttarajappa, MD, discusses viral infections post-kidney transplant.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Describe diagnostic testing for antiviral resistant cytomegalovirus (CMV) infection in kidney transplantation
- Recognize the role of letermovir for prevention and treatment of CMV in kidney transplantation
- Identify risk factors and approaches to BK virus (BKV) infection in kidney transplantation
Disclosures
Dr. Puttarajappa has reported no relevant relationships with entities producing health care goods or services.
All presenters' disclosures of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients is listed above. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers, and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Accreditation Statement
The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.1) continuing education units (CEUs) which are equivalent to 1.0 contact hours.
For your credit transcript, please access our website four weeks postcompletion at http://ccehs.upmc.com and follow the link to the Credit Transcript page.
Release Date: 9/24/2019 | Last Modified On: 9/24/2019 | Expires: 9/24/2020
